Skip to content

13F-HR filed by NEA Management Company, LLC

NEA Management Company, LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 32 holding rows worth $1,328,451,108.

Accession
0000897069-25-001334
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 32 entries on the cover page, a total value of $1,328,451,108 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,328,451,108 with VALUE read as dollars as filed, 13F file number 028-14302. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARCELLX INC COMMON STOCK03940C100Stock3,745,262$246,625,503dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS2,263,138$214,047,592dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM2,909,956$183,880,120dollars as filed
COURSERA INC COM22266M104Stock12,867,769$112,721,656dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock1,587,854$77,233,219dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock13,222,228$72,325,588dollars as filed
SAVARA INC805111101COM24,471,264$55,794,482dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM4,118,621$41,804,003dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock3,614,486$41,241,285dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM7,692,298$34,692,264dollars as filed
AURINIA PHARMACEUTICALS INC COM05156V102Stock3,969,834$33,624,494dollars as filed
CELCUITY INC15102K100COM2,294,261$30,628,384dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock2,733,719$26,489,737dollars as filed
GOSSAMER BIO INC COM38341P102Stock18,093,034$22,254,432dollars as filed
NEUEHEALTH INC10920V404COM NEW2,726,917$18,815,727dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK1,960,169$18,798,021dollars as filed
KORRO BIO INC500946108COMMON STOCK1,090,793$13,624,005dollars as filed
CHAMPIONS ONCOLOGY INC15870P307COM NEW1,713,720$12,630,116dollars as filed
CVRX INC126638105COMMON STOCK2,026,083$11,913,368dollars as filed
BLACK DIAMOND THERAPEUTICS I09203E105COM4,448,757$11,032,917dollars as filed
INOZYME PHARMA INC45790W108COM2,437,689$9,750,756dollars as filed
Senti Biosciences, Inc.81726A209COM NEW3,775,615$7,966,548dollars as filed
OMADA HEALTH INC68170A108COM364,115$6,663,305dollars as filed
NKARTA INC65487U108COMMON STOCK3,568,781$5,924,176dollars as filed
INVENTIVA SA46124U107ADS1,462,586$4,665,649dollars as filed
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR17,079,778$4,094,023dollars as filed
SYNLOGIC INC87166L209COM2,922,772$3,711,921dollars as filed
MARKER THERAPEUTICS INC57055L206COM NEW1,625,678$2,487,287dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A478,548$1,143,730dollars as filed
X4 Pharmaceuticals, Inc.98420X103COM499,559$949,162dollars as filed
IKENA ONCOLOGY INC45175G108COM600,063$804,084dollars as filed
WHEELS UP EXPERIENCE INC96328L205COM CL A106,125$113,554dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000897069-25-001334this filing2025-08-14acceptance time not in the bulk data set